Literature DB >> 10392641

Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques.

S O Vargas1, B A Sampson, F J Schoen.   

Abstract

The limitations of post mortem detection of early myocardial infarction by hematoxylin and eosin staining stimulated a search for the development of improved diagnostic methods based on biochemical and morphologic changes. Methods used and/or investigated included electron microscopic examination, gross and microscopic histochemical stains (tetrazolium salts, phosphotungstic acid-hematoxylin, trichrome, periodic acid-Schiff, hematoxylin-basic fuchsin-picric acid), fluorescence, immunohistochemical techniques, and chemical analysis of pericardial fluid. This practical review, designed for both forensic and hospital-based autopsy pathologists, examines the methods available for post mortem diagnosis of myocardial infarction for cases in which death might have occurred before the evolution of changes detectable by hematoxylin and eosin staining. The status and potential usefulness of each adjunct to classical morphologic examination is summarized. Recent developments are highlighted, including the possibility of using apoptosis as a marker for acute ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392641

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  Early markers for myocardial ischemia and sudden cardiac death.

Authors:  Sara Sabatasso; Patrice Mangin; Tony Fracasso; Milena Moretti; Mylène Docquier; Valentin Djonov
Journal:  Int J Legal Med       Date:  2016-07-08       Impact factor: 2.686

2.  Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death.

Authors:  Sara Sabatasso; Milena Moretti; Patrice Mangin; Tony Fracasso
Journal:  Int J Legal Med       Date:  2017-05-11       Impact factor: 2.686

Review 3.  Systematic review of fibrinolytic-facilitated percutaneous coronary intervention: potential benefits and future challenges.

Authors:  J Afilalo; A Michael Roy; M J Eisenberg
Journal:  Can J Cardiol       Date:  2009-03       Impact factor: 5.223

4.  Postmortem cardiac troponin-I levels predict intramyocardial damage at autopsy.

Authors:  Sara O Vargas; Christine Grudzien; Milenko J Tanasijevic
Journal:  J Thromb Thrombolysis       Date:  2007-12-07       Impact factor: 2.300

5.  Early intervention: which patients and how early?

Authors:  J Matthew Brennan; John L Petersen
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

6.  Age-related cardiac muscle sarcopenia: Combining experimental and mathematical modeling to identify mechanisms.

Authors:  Jing Lin; Elizabeth F Lopez; Yufang Jin; Holly Van Remmen; Terry Bauch; Hai-Chao Han; Merry L Lindsey
Journal:  Exp Gerontol       Date:  2007-12-15       Impact factor: 4.032

Review 7.  Matrix metalloproteinases and myocardial infarction.

Authors:  Wannakorn Phatharajaree; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

8.  Endoplasmic reticulum stress-related secretory proteins as biomarkers of early myocardial ischemia-induced sudden cardiac deaths.

Authors:  Bokang Yu; Chenchao Xu; Xinru Tang; Zheng Liu; Xinyi Lin; Hang Meng; Cheng Shi; Kaijun Ma; Bi Xiao; Liliang Li
Journal:  Int J Legal Med       Date:  2021-09-27       Impact factor: 2.686

9.  Guidelines for authors and reviewers on antibody use in physiology studies.

Authors:  Heddwen L Brooks; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-05       Impact factor: 4.733

Review 10.  Diagnosis of myocardial infarction at autopsy: AECVP reappraisal in the light of the current clinical classification.

Authors:  Katarzyna Michaud; Cristina Basso; Giulia d'Amati; Carla Giordano; Ivana Kholová; Stephen D Preston; Stefania Rizzo; Sara Sabatasso; Mary N Sheppard; Aryan Vink; Allard C van der Wal
Journal:  Virchows Arch       Date:  2019-09-14       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.